Last updated: 20 August 2024 at 4:06pm EST

John A. Bencich M.B.A. Net Worth




The estimated Net Worth of John Bencich is at least $1.2 millió dollars as of 19 April 2024. Mr Bencich owns over 25,000 units of Achieve Life Sciences stock worth over $435,379 and over the last 7 years he sold ACHV stock worth over $0. In addition, he makes $767,250 as CEO & Director at Achieve Life Sciences.

Mr A ACHV stock SEC Form 4 insiders trading

Mr has made over 14 trades of the Achieve Life Sciences stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 25,000 units of ACHV stock worth $107,000 on 19 April 2024.

The largest trade he's ever made was exercising 25,000 units of Achieve Life Sciences stock on 19 April 2024 worth over $107,000. On average, Mr trades about 4,286 units every 93 days since 2017. As of 19 April 2024 he still owns at least 101,724 units of Achieve Life Sciences stock.

You can see the complete history of Mr Bencich stock trades at the bottom of the page.





Mr. John A. Bencich M.B.A. biography

John A. Bencich M.B.A. is the CEO & Director at Achieve Life Sciences.

What is the salary of Mr A?

As the CEO & Director of Achieve Life Sciences, the total compensation of Mr A at Achieve Life Sciences is $767,250. There are 1 executives at Achieve Life Sciences getting paid more, with Richard Stewart having the highest compensation of $796,644.



How old is Mr A?

Mr A is 44, he's been the CEO & Director of Achieve Life Sciences since . There are 12 older and 3 younger executives at Achieve Life Sciences. The oldest executive at Achieve Life Sciences Inc. is Donald Joseph, 66, who is the Independent Director.

What's Mr A's mailing address?

John's mailing address filed with the SEC is 22722 29TH DR SE, SUITE 100, BOTHELL, WA, 98021.

Insiders trading at Achieve Life Sciences

Over the last 7 years, insiders at Achieve Life Sciences have traded over $972,224 worth of Achieve Life Sciences stock and bought 70,500 units worth $224,475 . The most active insiders traders include Capital, Llc Armistice Capi..., Vaughn B Himes és Jay M Moyes. On average, Achieve Life Sciences executives and independent directors trade stock every 65 days with the average trade being worth of $63,759. The most recent stock trade was executed by Jerry Wan on 19 April 2024, trading 5,625 units of ACHV stock currently worth $24,075.



What does Achieve Life Sciences do?

achieve life sciences is a specialty pharmaceutical company committed to advancing cytisine as a smoking cessation aid to overcome the global nicotine addiction epidemic.



What does Achieve Life Sciences's logo look like?

Achieve Life Sciences Inc. logo

Complete history of Mr Bencich stock trades at Achieve Life Sciences

Dátum
#
Cég
Az érdekelt
Trans.
Tranzakció
Részvények száma Ár per részvény Teljes ár Részvények szíma után Forrás
19 Apr 2024 John Bencich
CEO
Opció Gyakorlat 25,000 $4.51 $112,750
19 Apr 2024
101,724
4 Mar 2024 John Bencich
CEO
Megvenni 10,000 $4.59 $45,900
4 Mar 2024
76,724
30 May 2023 John Bencich
CEO
Megvenni 5,000 $5.50 $27,500
30 May 2023
66,730
28 Apr 2023 John Bencich
CEO
Opció Gyakorlat 7,500 $8.33 $62,475
28 Apr 2023
63,557
21 Apr 2023 John Bencich
CEO
Opció Gyakorlat 25,000 $8.05 $201,250
21 Apr 2023
61,920
18 Nov 2022 John Bencich
CEO
Megvenni 22,000 $2.39 $52,580
18 Nov 2022
36,920
28 Apr 2022 John Bencich
CEO
Opció Gyakorlat 7,500 $6.95 $52,125
28 Apr 2022
13,688
17 Aug 2021 John Bencich
CEO
Opció Gyakorlat 68 $6.83 $464
17 Aug 2021
6,209
27 May 2021 John Bencich
CEO
Megvenni 6,000 $7.00 $42,000
27 May 2021
6,141
18 Aug 2020 John Bencich
CEO
Opció Gyakorlat 69 $9.03 $623
18 Aug 2020
174
13 Aug 2019 John Bencich
CEO
Opció Gyakorlat 1,370 $1.90 $2,603
13 Aug 2019
2,509
15 Jan 2019 John Bencich
CEO
Opció Gyakorlat 28 $1.42 $40
15 Jan 2019
1,148
13 Aug 2018 John Bencich
CEO
Opció Gyakorlat 1,443 $3.05 $4,401
13 Aug 2018
1,578
8 Sep 2017 John Bencich
CEO
Opció Gyakorlat 454 $31.60 $14,346
8 Sep 2017
1,507


Achieve Life Sciences executives and stock owners

Achieve Life Sciences executives and other stock owners filed with the SEC include: